The Ins and Outs of Value-Based Contracts: Timing, Evidence, and Risk Alignment

EP: 1.Industry Voices on Current Pricing and Reimbursement Models

EP: 2.Navigating Regulatory Barriers within Market Access

EP: 3.Effective Real-World Evidence for Adding Value to a Clinical Trial

EP: 4.Harmonizing the Payer Perspective with Real-World Evidence

EP: 5.Challenges for Bringing Orphan Drugs to Market

EP: 6.Strategies in Today’s Market for Pricing and Reimbursement Models

Now Viewing

EP: 7.The Ins and Outs of Value-Based Contracts: Timing, Evidence, and Risk Alignment

EP: 8.How New Policies are Impacting Market Sustainability

EP: 9.Rethinking Market Strategy within a Patient-Centric Era

There is no shortcut to executing a value-based contract. In this episode, experts lay out what’s required to bring these agreements to life: evidence alignment, data compatibility, and mutual incentive. Payers want results, not just risk transference—and developers must understand and speak to payer business goals.

Key discussion topics include:

• Timeline and prerequisites for executing value-based contracts.
• Understanding what matters to payers vs. regulators.
• How to prototype contracting models for early feedback.
• The importance of strong head-to-head clinical data as the foundation.